The National Kidney Foundation recently released the first guidelines regarding the management of hypertension in those with CKD. The guidelines, which were developed by the Foundation?s Kidney Disease Outcomes Quality Initiative (K/DOQI), were published as a supplement to the May 2004 issue of the American Journal of Kidney Diseases.
How Differences in Bispecific Therapies Impact Myeloma Treatment Operations
April 18th 2024According to Kirollos Hanna, PharmD, although similarities exist between bispecific therapies in the myeloma space, health care providers should take special note of practical differences and nuances associated with each when operationalizing them at their site of care.